logo
  • Resources by Tumor Type
  • Provider Resources
    • Care Step Pathways
    • Continuing Education
    • Provider Toolkits
    • Healthcare Disparities
      • Primer
      • Videos
    • ctDNA Testing for Response Monitoring
    • News
  • Patient/Caregiver Resources
    • Patient Action Plans
    • Caregiver Resource
    • Options for Stage IV Melanoma
    • Options for Stage III Melanoma
    • Options for Stage II Melanoma
    • Non-Invasive Evaluation Tools (Melanoma)
    • ctDNA Testing Handout
  • International Resources
    • Australia
    • Canada
    • France
    • Germany
    • Italy
    • Portugal
    • Spain
    • UK
  • Videos
    • HCP Videos
    • Patient Videos
  • Resources by Tumor Type
  • Provider Resources
    • Care Step Pathways
    • Continuing Education
    • Provider Toolkits
    • Healthcare Disparities
      • Primer
      • Videos
    • ctDNA Testing for Response Monitoring
    • News
  • Patient/Caregiver Resources
    • Patient Action Plans
    • Caregiver Resource
    • Options for Stage IV Melanoma
    • Options for Stage III Melanoma
    • Options for Stage II Melanoma
    • Non-Invasive Evaluation Tools (Melanoma)
    • ctDNA Testing Handout
  • International Resources
    • Australia
    • Canada
    • France
    • Germany
    • Italy
    • Portugal
    • Spain
    • UK
  • Videos
    • HCP Videos
    • Patient Videos
Avatar photo
  • Profile
  • Topics Started
  • Replies Created
  • Engagements
  • Favorites

Topics Engaged In

Viewing 8 topics - 16 through 23 (of 23 total)
← 1 2
    • Topic
    • Voices
    • Posts
    • Last Post
    • Pre-existing rheumatologic conditions

      Started by: Avatar photoLisa Kottschade in: Side-effect management

    • 3
    • 3
    • January 5, 2018 at 2:50 am

      Virginia Seery

    • Infusion reactions

      Started by: LisaTushla in: Dosing and administration

    • 3
    • 3
    • December 24, 2017 at 4:11 pm

      Kathleen Madden

    • Pharmacy and nurse roles

      Started by: LisaTushla in: Dosing and administration

    • 3
    • 3
    • December 24, 2017 at 4:06 pm

      Kathleen Madden

    • BRAF/MEK inhibitors and statins

      Started by: Avatar photoLisa Kottschade in: Side-effect management

    • 3
    • 6
    • December 14, 2017 at 4:47 pm

      Virginia Seery

    • Herbal medications

      Started by: Avatar photoLisa Kottschade in: Alternative/complementary therapies

    • 2
    • 2
    • November 30, 2017 at 8:08 pm

      Virginia Seery

    • VIvid dreams

      Started by: Avatar photoKrista Rubin in: Other

    • 3
    • 3
    • November 15, 2017 at 8:29 pm

      Lisa Kottschade

    • Targeted therapies for adjuvant therapy

      Started by: LisaTushla in: Expectations for therapy

    • 2
    • 2
    • November 3, 2017 at 2:07 am

      Virginia Seery

    • Finacial toxicity

      Started by: Avatar photoKrista Rubin in: Other

    • 2
    • 2
    • November 3, 2017 at 1:32 am

      Virginia Seery

  •  

Viewing 8 topics - 16 through 23 (of 23 total)
← 1 2

Login

Log In
Register Lost Password

Latest Activity

  • New BRAF/MEK inhibitors coming to market
    topic by Lisa Kottschade
    March 1
    in Dosing and administration
  • Adjuvant Immunotherapy in stage IIIA patients
    topic by Lisa Kottschade
    March 1
    in Expectations for therapy
  • Influenza and Tamiflu and Immunotherapy
    reply by Kathleen Madden
    February 25
    in Other
  • ASCO/NCCN guidlines now out
    reply by Mollie Reed
    February 23
    in Side-effect management
  • hepatotoxicity
    reply by Mollie Reed
    February 23
    in Side-effect management
© 2023 ImmunoHub.org. All rights reserved.
  • About
  • Terms
  • Privacy
  • Contact